Skip to main content
. 2022 Jan-Mar;26(1):e2021.00086. doi: 10.4293/JSLS.2021.00086

Table 2.

Univariate Analysis of 30-Day Postoperative Outcomes

30-Day Postoperative Outcomes Control (n = 8,725) End Stage RenalDisease (n = 64) p-Value
Postoperative Length of Stay, median (standard deviation), days 0 (2.5) 1 (8.6) 0.1608
Superficial Wound Infection (%) 49 (0.6) 0 (0.0) 1.0
Deep Wound Infection (%) 12 (0.1) 0 (0.0) 1.0
Organ Space Infection (%) 20 (0.2) 1 (1.6) 0.1424
Dehiscence (%) 4 (0.1) 1 (1.6) 0.0359
Pneumonia (%) 36 (0.4) 4 (6.3) 0.0002
Reintubation (%) 26 (0.3) 1 (1.6) 0.1793
Failure to Wean from Ventilator (%) 17 (0.2) 1 (1.6) 0.1234
Pulmonary Embolism (%) 12 (0.1) 0 (0.0) 1.0
Deep Vein Thrombosis (%) 19 (0.2) 0 (0.0) 1.0
Cerebrovascular Accident (%) 5 (0.1) 0 (0.0) 1.0
Myocardial Infarct (%) 14 (0.2) 0 (0.0) 1.0
Cardiac Arrest (%) 7 (0.1) 0 (0.0) 1.0
Bleeding Requiring Transfusions (%) 31 (0.4) 2 (3.2) 0.0238
Sepsis (%) 26 (0.3) 2 (3.2) 0.0175
Septic Shock (%) 13 (0.2) 0 (0.0) 1.0
Return to Operating Room (%) 98 (1.1) 3 (4.7) 0.0371
Death (%) 16 (0.2) 0 (0.0) 1.0